Language selection

Search

Details for: NEULASTA

Company: AMGEN CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02249790NEULASTAPEGFILGRASTIM10 MG / MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: